Week's top
Latest news
Unread news
Subscribe

Science X Account

Sign in with

Forget Password?

Not a member? Sign up

Allergy and immunology
Anesthesiology
Cardiology
Clinical genetics
Critical care medicine
Dermatology
Diagnostic radiology
Emergency medicine
Endocrinology
Family medicine
Gastroenterology
General surgery

Geriatric palliative care
Preventive medicine
Hospital medicine
Infectious diseases
Nephrology
Neurology
Obstetrics & gynecology
Oncology
Ophthalmology
Orthopedics
Pediatrics
Physiatry

Psychiatry
Pulmonary medicine
Rheumatology
Sleep medicine
Urology
Dentistry
Allied health
Occupational medicine
Sports medicine
Clinical pharmacology
Laboratory medicine

Healthy living
Nutrition & Healthy eating
Weight management
Fitness & Physical activity

Sleep & Recovery
Psychology & Mental health
Women's health
Men's health

Children's health
Healthy aging
Skin & Hair care
Common illnesses & Prevention

Digestive health
Reproductive health
Pregnancy
HIV & AIDS

Amblyopia
Antisocial Personality Disorder
Borderline Personality Disorder
Bronchitis
Carpal Tunnel Syndrome
Chickenpox
Chikungunya
Cholangiocarcinoma
Death
Developmental Disabilities
Diabetic Neuropathies
Dyslexia

Dyssomnias
Endolymphatic Hydrops
Eosinophilic Esophagitis
Gastroparesis
Hair Loss
Head and neck squamous cell carcinoma
Hemophilia A
Hepatitis A
Hyponatremia
Lassa Fever
Liver Cancer
Low Blood Pressure

Muscular Atrophy
Neoplasm, Residual
Neural Tube Defects
Noncommunicable Diseases
Otitis Media
Paralysis
Peptic Ulcer
Pregnancy Complications
Premenstrual Syndrome
Proteinuria
Rare Diseases
REM Sleep Behavior Disorder

Rubella
Sarcoma
Stomach Cancer
Sunburn
Tauopathies
Testicular Neoplasms
Tourette Syndrome
Valley Fever
Vertigo
Vitiligo
Wounds, Gunshot
Browse all »

Home
Archive
29/08/2022

Archive: 29/08/2022

Costlier Medicare Advantage plans do not always offer better quality

Enrolling in a higher-cost Medicare Advantage plan may not always get seniors better quality health care, according to a new RAND Corporation study.

Aug 29, 2022

0

60

Stolen DNA strengthens immune diversity

A few years ago, Professor Kathrin de la Rosa and her colleagues in the lab of the Swiss immunologist Antonio Lanzavecchia made an unusual discovery. The team found antibodies in the blood of malaria patients that had been ...

Aug 29, 2022

0

111

Study examines support programs for pregnant, postpartum people at state prisons

Published in the Journal of Criminal Justice, researchers from the University of Minnesota Medical School examined the variation of support programs for pregnant and postpartum people at six state prisons in the U.S. The ...

Aug 29, 2022

0

5

For kids with kidney disease, pediatric expertise is key—but not always close by

Jaxon Green, 6, was diagnosed with kidney disease the day he was born. His illness meant that for years his life would depend on daily dialysis. And because his family lives in Tamaqua, a rural Pennsylvania town, his diagnosis ...

Aug 29, 2022

0

10

Top-selling drug Farxiga sees potential to reach more patients

One of AstraZeneca Plc's top-selling drugs Farxiga, a diabetes treatment, is beneficial to a wider pool of patients than previously indicated, a study shows, bolstering the product's blockbuster potential.

Aug 29, 2022

0

5

Tips for reducing dementia risk

More than 55 million people worldwide are believed to be living with dementia, according to the World Health Organization. Ronald Petersen, M.D., a neurologist and director of Mayo Clinic's Alzheimer's Disease Research Center, ...

Aug 29, 2022

0

20

How young athletes can reduce their risk of injury

More than half of children in the U.S. ages 6 to 17 participate in sports. With participation also comes the painful reality of injuries that happen during gameplay.

Aug 29, 2022

0

16

Shift workers with high blood pressure may face higher heart disease, diabetes risk

People with high blood pressure may be at higher risk for developing cardiovascular disease and diabetes if they work frequent night shifts, new research suggests.

Aug 29, 2022

0

8

FDA approves Imbruvica for pediatric chronic graft versus host disease

The U.S. Food and Drug Administration has approved Imbruvica (ibrutinib) for pediatric patients with chronic graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy.

Aug 29, 2022

0

13

Factory at center of baby formula recall will produce Similac again soon

Roughly six months after it shut down its baby formula plant in Michigan, Abbott Laboratories said it plans to begin making Similac again.

Aug 29, 2022

0

4

page 2 from 11

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Support us
Science X Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2026 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us